Was können Register leisten?: Warum Real World Data zur Versorgungsrealität aus Registern so wichtig sind

por Griesinger, Frank, Jänicke, Martina
Publicado 2022

The potassium channel Ether à go-go is a novel prognostic factor with functional relevance in acute myeloid leukemia

por Agarwal, Jasmin R, Griesinger, Frank, Stühmer, Walter, Pardo, Luis A
Publicado 2010

Clinical benefit and cost-effectiveness analysis of liquid biopsy application in patients with advanced non-small cell lung cancer (NSCLC): a modelling approach

por Englmeier, Fabienne, Bleckmann, Annalen, Brückl, Wolfgang, Griesinger, Frank, Fleitz, Annette, Nagels, Klaus
Publicado 2022

Fludarabine combined with radiotherapy in patients with locally advanced NSCLC lung carcinoma: a phase I study

por Nitsche, Mirko, Christiansen, Hans, Lederer, Katinka, Griesinger, Frank, Schmidberger, Heinz, Pradier, Olivier
Publicado 2012

Needs of Lung Cancer Patients Receiving Immunotherapy and Acceptance of Digital and Sensor-Based Scenarios for Monitoring Symptoms at Home—A Qualitative-Explorative Study

por von Kutzleben, Milena, Galuska, Jan Christoph, Hein, Andreas, Griesinger, Frank, Ansmann, Lena
Publicado 2022

Brain metastases in ALK-positive NSCLC – time to adjust current treatment algorithms

por Griesinger, Frank, Roeper, Julia, Pöttgen, Christoph, Willborn, Kay C., Eberhardt, Wilfried E.E.
Publicado 2018

Real-world treatment and survival of patients with advanced non-small cell lung Cancer: a German retrospective data analysis

por Hardtstock, Fränce, Myers, David, Li, Tracy, Cizova, Diana, Maywald, Ulf, Wilke, Thomas, Griesinger, Frank
Publicado 2020

Trial on Refinement of Early stage non-small cell lung cancer. Adjuvant chemotherapy with pemetrexed and cisplatin versus vinorelbine and cisplatin: The TREAT protocol

por Kreuter, Michael, Vansteenkiste, Johan, Griesinger, Frank, Hoffmann, Hans, Dienemann, Hendrik, De Leyn, Paul, Thomas, Michael
Publicado 2007

Acquired G2032R Resistance Mutation in ROS1 to Lorlatinib Therapy Detected with Liquid Biopsy

por Jóri, Balázs, Falk, Markus, Hövel, Iris, Weist, Peggy, Tiemann, Markus, Heukamp, Lukas C., Griesinger, Frank
Publicado 2022

Use of algorithms for identifying patients in a German claims database: learnings from a lung cancer case

por Neugebauer, Sina, Griesinger, Frank, Dippel, Sabine, Heidenreich, Stephanie, Gruber, Nina, Chruscz, Detlef, Lempfert, Sebastian, Kaskel, Peter
Publicado 2022

TP53 co-mutations as an independent prognostic factor in 2nd and further line therapy—EGFR mutated non-small cell lung cancer IV patients treated with osimertinib

por Roeper, Julia, Christopoulos, Petros, Falk, Markus, Heukamp, Lukas C., Tiemann, Markus, Stenzinger, Albrecht, Thomas, Michael, Griesinger, Frank
Publicado 2022

Association Between Smoking History and Overall Survival in Patients Receiving Pembrolizumab for First-Line Treatment of Advanced Non–Small Cell Lung Cancer

por Popat, Sanjay, Liu, Stephen V., Scheuer, Nicolas, Gupta, Alind, Hsu, Grace G., Ramagopalan, Sreeram V., Griesinger, Frank, Subbiah, Vivek
Publicado 2022

Addressing challenges with real-world synthetic control arms to demonstrate the comparative effectiveness of Pralsetinib in non-small cell lung cancer

por Popat, Sanjay, Liu, Stephen V., Scheuer, Nicolas, Hsu, Grace G., Lockhart, Alexandre, Ramagopalan, Sreeram V., Griesinger, Frank, Subbiah, Vivek
Publicado 2022

European and US Real-World Treatment Patterns in Patients with Epidermal Growth Factor Receptor Mutation-Positive Non-Small Cell Lung Cancer: A Retrospective Medical Record Review

por Shah, Riyaz, Girard, Nicolas, Nagar, Saurabh P., Griesinger, Frank, Roeper, Julia, Davis, Keith L., Karimi, Parisa, Sawyer, William, Yu, Ning, Taylor, Aliki, Feliciano, Josephine
Publicado 2021

TP53 co-mutations in EGFR mutated patients in NSCLC stage IV: A strong predictive factor of ORR, PFS and OS in EGFR mt+ NSCLC

por Roeper, Julia, Falk, Markus, Chalaris-Rißmann, Athena, Lueers, Anne C., Ramdani, Hayat, Wedeken, Katrin, Stropiep, Ursula, Diehl, Linda, Tiemann, Markus, Heukamp, Lukas C., Otto-Sobotka, Fabian, Griesinger, Frank
Publicado 2020

Comparison of Resistance Spectra after First and Second Line Osimertinib Treatment Detected by Liquid Biopsy

por Jóri, Balázs, Schatz, Stefanie, Kaller, Len, Kah, Bettina, Roeper, Julia, Ramdani, Hayat O., Diehl, Linda, Hoffknecht, Petra, Grohé, Christian, Griesinger, Frank, Tiemann, Markus, Heukamp, Lukas C., Falk, Markus
Publicado 2021

Transportability of Overall Survival Estimates From US to Canadian Patients With Advanced Non–Small Cell Lung Cancer With Implications for Regulatory and Health Technology Assessme...

por Ramagopalan, Sreeram V., Popat, Sanjay, Gupta, Alind, Boyne, Devon J., Lockhart, Alexandre, Hsu, Grace, O’Sullivan, Dylan E., Inskip, Jessica, Ray, Joshua, Cheung, Winson Y., Griesinger, Frank, Subbiah, Vivek
Publicado 2022

Afatinib as first-line treatment in patients with EGFR-mutated non-small cell lung cancer in routine clinical practice

por Brückl, Wolfgang M., Reck, Martin, Griesinger, Frank, Schäfer, Harald, Kortsik, Cornelius, Gaska, Tobias, Rawluk, Justyna, Krüger, Stefan, Kokowski, Konrad, Budweiser, Stephan, Ficker, Joachim H., Hoffmann, Christopher, Schüler, Andrea, Laack, Eckart
Publicado 2021

Integration of Tumor Mutation Burden and PD-L1 Testing in Routine Laboratory Diagnostics in Non-Small Cell Lung Cancer

por Schatz, Stefanie, Falk, Markus, Jóri, Balázs, Ramdani, Hayat O., Schmidt, Stefanie, Willing, Eva-Maria, Menon, Roopika, Groen, Harry J. M., Diehl, Linda, Kröger, Matthias, Wesseler, Claas, Griesinger, Frank, Hoffknecht, Petra, Tiemann, Markus, Heukamp, Lukas C.
Publicado 2020

Decision Conflicts in Clinical Care during COVID-19: A Patient Perspective

por Haier, Jörg, Beller, Johannes, Adorjan, Kristina, Bleich, Stefan, De Greck, Moritz, Griesinger, Frank, Hein, Alexander, Hurlemann, René, Mees, Sören Torge, Philipsen, Alexandra, Rohde, Gernot, Schilling, Georgia, Trautmann, Karolin, Combs, Stephanie E., Geyer, Siegfried, Schäfers, Jürgen
Publicado 2022